Atlas Trials

Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease

Clinical trial NCT03319810 · COMPLETED

Trial details

NCT number
NCT03319810
Sponsor
Sutter Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2018-01-04
Primary completion
2018-07-19
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.